Protective Effect of Xueshuan Xinmaining Capsules on Experimental Myocardial Infarction in Rats

Yang Chunmei,LIU Bing,SUI Dayuan,Yu Xiaofeng,QU Shaochun
DOI: https://doi.org/10.3969/j.issn.1004-3594.2005.05.010
2005-01-01
Abstract:Objective To study the protective effect of Xueshuan Xinmaining (XSXMN) capsules on experimental myocardial infarction in rats.Methods The changes in myocardial infarct size(MIS), the serum creatine phosphokinase(CK), lactate dehydrogenase(LDH), superoside dismutase(SOD) activities, the serum lipid peroxidation(LPO) and myocardial free fatty acid(FFA) contents,and plasma prostacycline(PGI 2) and thromboxane (TXA 2) levels were determined in rats models with acute myocardial infarction induced by ligating the left anterior descending coronary artery(LAD).Results In rats treated by XSXMN (in a dosage of 2 and 4g/kg ig.for 7 days ), the sizes of acute myocardial infarction were significantly reduced, the serum CK, LDH activities,the plasma TXA 2 levels and myocardial FFA contents were declined, while PGI 2 level and PGI 2/TXA 2 ratio was increased significantly. In addition, serum LPO content was declined, SOD activity was increased markedly.Conclusions XSXMN capsules has protective effect on myocardial ischemia probably by improving free radicals metabolism and myocardial metabolism and increasing plasma PGI 2/TXA 2 ratio. Therefore,XSXMN capsules is an effective drug for treatment of myocardial ischemia.
What problem does this paper attempt to address?